CD38 protein, which was discovered in 1980, is a type II transmembrane glycoprotein with a size of 46 kDa. The ligand of CD38 is CD31, also known as PECAM-1, which is aRead More…
Cell: Isolated Strong SARS-CoV-2 Neutralizing Antibody from Patients with COVID-19
An important line of defense against novel coronavirus SARS-CoV-2 is the formation of neutralizing antibodies. These antibodies can eliminate invaders and have great potential in the prevention and treatment of SARS-CoV-2 infection.Read More…
Nature: Major Discovery! A Human Antibody Can Strongly Neutralize A Variety of Coronaviruses, including SARS-CoV and SARS-CoV-2
In a new study, researchers from Humabs Biomed SA and the University of Washington found that an antibody that suppresses the associated coronavirus was identified for the first time in a bloodRead More…
Big News! Microbes Control the Health of the Immune System!
Researchers from Charité-Universitätsmedizin Berlin, Berlin Institute of Health and Deutsches Rheuma-Forschungszentrum, together with other scientists, have shown how microbes help the immune system respond to pathogens. Without the relevant mediators, the metabolicRead More…
Science: COVID-19 May Relapse Seasonally and the High Temperature in Summer will not Make It Die
Researchers at Harvard University studied the common cold for clues to how the COVID-19 virus might behave. They used close relatives of SARS-CoV-2 to simulate its behavior in the coming months. TheRead More…
National Institutes of Health (NIH) Has Launched a Clinical Trial of Remdesivir in the Treatment of COVID-19
Nebraska is conducting the first clinical trial of possible coronavirus treatment, which is expected to eventually include 400 patients in 50 locations around the world, officials said. In this international study, halfRead More…
Summary of New Drugs with Clinical Trial Progress Approved by FDA in 2019
Innovation drives progress. Center for Drug Evaluation and Research (CDER) of FDA has been a strong supporter of innovation in the development of new drugs and biotherapy products. By understanding the mechanismRead More…
Breakthrough! Scientists Have Successfully Reprogrammed T Cells to Improve the Efficacy of Cancer Immunotherapy
In a study published in Nature, scientists from St. Jude’s Children’s Research Hospital and other institutions have developed a new treatment strategy to effectively enhance cancer immunotherapy, which may effectively slow tumorRead More…
A New Antibody is Expected to be Developed as a General Influenza Vaccine
A team of researchers from the United States have found that an antibody that “embeds” influenza virus surface proteins can protect mice from a variety of influenza virus strains and is expectedRead More…
Comprehensive Analysis of Targeted Drugs for Lung Cancer
Incidence of lung cancer Lung cancer has the highest incidence of cancer in the world. According to WHO’ statistics, there are an estimated 18.1 million new cancer patients worldwide in 2018, ofRead More…